Radu Rapiteanu

Scientific Investigator
GlaxoSmithKline
Radu is a Scientific Investigator in Functional Genomics at GSK, with experience in applying CRISPR screens in complex primary cell models to identify novel disease modulating genes. He is currently leading a team focussing on developing CRISPR-based pipelines for translating immune disease associated genetic variants into mechanistic knowledge of disease. Radu received a PhD from the University of Cambridge, where his work revolved around genetic and proteomic screens to identify novel HIV restriction factors.

Sessions

November 7 2019, 18:20
 - 18:50
Arrayed And Pooled CRISPR Screening In A Complex Primary Cell Model Of The Human Airway